跳至主要内容
临床试验/NCT04570033
NCT04570033已完成不适用

The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas

Military Institute od Medicine National Research Institute0 个研究点目标入组 65 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
主要终点
The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas

研究概览

简要总结

We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism (PHPT).

详细描述

We prospectively enrolled 65 consecutive patients with PHPT who underwent neck ultrasound (US) and parathyroid scintigraphy (99mTc/99mTc-MIBI dual phase). Twenty-two patients had unsuccessful parathyroid surgery prior to the study. PET/CT scans were performed 65.0 ± 13.3 min after injection of 218.5 ± 31.9 MBq of 18F-fluorocholine (FCH). Three experienced nuclear medicine physicians assessed the detection rate of hyperfunctioning parathyroid tissue. Response to parathyroidectomy and clinical follow-up served as a reference test. Per-patient sensitivity and positive predictive value (PPV) were calculated for patients who underwent surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • primary hyperparathyroidism and neck US and the dual-phase 99mTc/99mTc-MIBI SPECT/CT scintigraphy performed prior to the PET/CT scan

排除标准

  • pregnancy
  • patient's lack of consent to the examination

结局指标

主要结局

The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas

时间窗: 24 months

Sensitivity and positive predictive value of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism

次要结局

未报告次要终点

研究者

发起方
Military Institute od Medicine National Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrzej Mazurek

MD PhD

Military Institute od Medicine National Research Institute

相似试验